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Abstract
Numerous in vitro experiments have confirmed that a dysfunctional endothelium is character-
ized by, inter alia, a higher affinity for binding of platelets and leukocytes. However, there is still
no direct evidence for greater interaction between platelets and intact endothelium in in vivo
animal models of diabetes. Therefore, the present study examines the pro-adhesive properties
of endothelium change in vivo as an effect of streptozotocin (STZ)-induced diabetes and the
role of two key platelet receptors: GPIb-IX-V and GPIIb/IIIa.
Mice of C57BL strain with streptozotocin-induced diabetes were used in the study. Flow cyto-
metry was used to assess basal activation and reactivity of platelets. Adhesion of platelets to the
vascular wall was visualized with the use of intravital microscopy in mesentery. The contribution
of GPIIb/IIIa and GPIb-IX-V was evaluated by the injection of Fab fragments of respective
antibodies. The integrity of the endothelium and vWf expression were evaluated histochemically.
Basal activation and reactivity of platelets in streptozotocin-diabetic mice were elevated. Blood
platelets adhered more often to the vascular wall of diabetic mice than nondiabetic animals:
11.9 (6.4; 32.8) plt/min/mm2 (median [IQR]) vs 2.7 (1.3; 6.4) plt/min/mm2. The injection of anti-
GPIbα antibodies decreased the number of adhering platelets from 89.5 (34.0; 113.1) plt/min/
mm2 (median [IQR]) in mice treated with isotype antibodies to 3.1 (1.7; 5.6) plt/min/mm2 in
mice treated with blocking antibodies. The effect of GPIIb/IIIa blockage was not significant.
Immunohistochemistry revealed a higher expression of vWF in the endothelium of STZ mice,
but no substantial changes in endothelial morphology were detected.
To conclude, the study shows that the platelets interact more frequently with the mesenteric
vascular bed in mice with 1-month STZ-induced diabetes than in healthy mice. These interac-
tions are mediated via platelet GPIb-IX-V and are driven by increased expression of vWF in
endothelial cells.
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Introduction
Besides other abnormalities, a dysfunctional endothelium is charac-
terized by a higher affinity for binding of platelets and leukocytes,
and this has been proven in numerous in vitro studies, as well as in
the in vivo studies based on various animal models of endothelial
dysfunction [1–5]. This pro-inflammatory state of a dysfunctional
endothelium is considered to be a primary cause for the development
of atherosclerosis [6]. It is suggested that the interaction between
platelets and the inflamed endothelium facilitates the adhesion of
monocytes to the vascular wall, which is recognized as a first step in
the development of atherosclerotic lesions.
Diabetes mellitus (DM) is a metabolic condition associated with
the dysregulation of the cardiovascular system. The inflammation of
the endothelium and increased activation of blood platelets are
strongly associated with this disease in humans [7]. Both of these
abnormalities are also reproduced in animal models of diabetes.
Increased basal activation and reactivity of platelets [8–12] and
endothelial dysfunction [13–16] have been shown in animal models
representing human models of type I and type II diabetes. However,
no direct evidence exists which suggests that the interactions
between platelets and the intact endothelium in vivo are enhanced
in an animal model of diabetes. Therefore, the aim of the present
study is to examine how the pro-adhesive properties of the endothe-
lium change in streptozotocin-induced diabetes in an in vivo model,
one of the most often used rodent models of DM corresponding to
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human type 1 diabetes. The study also determines the role of two
platelet receptors, which are recognized as being chiefly involved in
this process, namely GPIb-IX-V and GPIIb/IIIa.
Materials and methods
Materials
Male C57BL mice aged 8–12 weeks were obtained from the
Center of Experimental Medicine, Medical University of
Bialystok (Bialystok, Poland).
Blood platelet-specific DyLight488-labeled anti-GPIbβ antibo-
dies for in vivo labeling, isotype antibodies for blocking experi-
ments (non-immune rat IgG), FITC- and PE-conjugated rat anti-
CD41/61, PE-conjugated rat anti-CD62P, PE-conjugated JON/A
antibodies (rat anti-active complex GPIIb/IIIa), FITC-conjugated
rat anti-von Willebrand factor antibodies were purchased from
Emfret Analytics (Eibelstadt, Germany). Fab fragments of the
monoclonal anti-GPIbα antibodies Xia.B2 clone and anti GPIIb/
IIIa Leo.H4 clone were a kind gift from Emfret. Streptozotocin
(STZ) and protease-activated receptor-4 (PAR-4) activating pep-
tide (AYPGKF) were purchased from Sigma (St. Louis, MO,
USA). Mouse von Willebrand factor A2 Elisa Kit was obtained
from Abcam (Cambridge, UK). Materials for histochemistry were
purchased from Sigma, Menzel Gläser (Braunschweig, Germany).
Normal goat serum and Cy3-conjugated secondary goat-anti-rab-
bit antibody for immunohistochemistry were purchased from
Jackson Immuno (West Grove, PA, USA) and primary rabbit-




The studies were approved by the Local Ethical Committee on
Animal Experiments, Medical University of Lodz (approval num-
ber 65/LB572/2011). Experimental diabetes was induced in
C57BL 8-week-old mice by intraperitoneal injection of 200 mg/
kg b.w STZ in 0.1 mol/l citrate buffer (pH 4.5). Control mice
were injected with a vehicle. STZ-diabetic animals, in which
blood glucose values exceeded 16.6 mmol/l 7 days after STZ
injection, were recruited to the study. Measurements of glucose
levels were conducted daily.
Analysis of platelet count and size
Blood was collected on K2EDTA pH 7.3, from the inferior vena
cava. Platelet count and size were then analyzed with a sciI Vet abc
Plus + veterinary hematological analyzer (Horiba, Kyoto, Japan).
Assessment of platelet adhesion to vascular wall with the
use of in vivo microscopy
Thirty days after injection, the mice were anesthetized, injected with
platelet-specific fluorescent anti-GPIbβ antibodies at a dose of 0.1
µg/g b.w. and placed on the stage of an upright microscope equipped
with saline immersion objectives. The antibodies do not interfere
with the interaction between GPIbα and vWF. The mesentery was
exteriorized and fixed in a chamber allowing constant superfusion
with saline. Imaging was carried out for 40 seconds with an exposure
time of 200 ms in at least three sites of the mesenteric vascular bed
in each mouse. In the experiment testing the effect of blocking
antibodies, the anti-GPIα Fab fragments, anti-GPIIb/IIIa Fab frag-
ments, or nonimmune rat IgG antibodies (control), were injected into
the tail vein at a dose of 60 μg per mouse.
The analysis of platelet adhesion was performed with the use
of ImageJ software supported with the MTrackJ plugin [17].
Measurements of blood platelet adhesion to von Willebrand
factor in vitro
Blood platelet adhesion was assessed with the use of the
VenaFlux platform (Cellix, Dublin, Ireland). The channels of a
Vena8 Fluo + biochip were coated with von Willebrand factor (20
µg/ml) overnight at 4°C and blocked with BSA (1 mg/ml) for 1
hour at 4°C. The biochip was mounted on a thermically controlled
stage of an inverted AxioVert microscope (Carl Zeiss,
Oberkochen, Germany) assuring a constant temperature of 37°C
throughout the experiment. Prior to measurements the channels
were washed with PBS. The blood was collected on heparin from
the inferior vena cava and fluorescent anti-GPIbβ antibodies were
added: the same as those used for intravital microscopy. After a 5-
minute incubation, the blood was perfused through the channel at
20 dynes/cm2 for 5 minutes. Images were taken using a 40x
objective at an exposure time of 2 seconds at five different sites
along the channel using a filter set dedicated for FITC. Platelets,
which did not change their position during exposure (2 seconds),
were imaged as discoid objects, while those displaced in this
timeframe were imaged as smears. The results of the experiment
were quantified by counting only the discoid objects in five
defined areas in each of the images.
Flow cytometry analysis
The blood was centrifuged and cellular blood components were
suspended in Tyrode’s buffer as described previously [10]. The
activation of circulating platelets, and the platelet reactivity in
response to PAR-4 activating peptide (AYPGKF), at final con-
centrations of 20 or 100 µM, were evaluated by measuring the
expression of the specific surface membrane antigens CD62P (P-
selectin) and activated GPIIb/IIIa complex, as well as the binding
of endogenous von Willebrand factor to the platelet surface.
Platelets were gated on the basis of the binding of anti-GPIIb/
IIIa antibodies. Flow cytometric measurements of platelet surface
membrane antigens were performed with the use of light scatter
(threshold 200) and fluorescence gates set on the platelet fraction.
The green or orange fluorescence of the stained platelets was
recorded for FITC (filter transmitting at 530 nm, with a band-
width of 30 nm) and PE (filter transmitting at 585 nm, with a
bandwidth of 42 nm), respectively, using the FACS Canto II
instrument (BD Biosciences, San Jose, CA) with the excitation
set at 488 nm. At least 10 000 cells were analyzed per sample. All
data were processed using FACS/Diva ver. 6.0 software (BD
Biosciences, San Jose, CA).
The percent fractions of specific fluorescence-positive platelets
were evaluated after subtracting the binding of nonspecific isotype
mouse IgG1. The gate for isotype control was set to 2%. Results were
presented as the percent fractions and MFI values for CD62P-,
activated αIIbβ3- and vWf-positive platelets. Additionally, platelet
size measurement was used to distinguish between cohorts of newly
produced (larger, referred to as “fresh”) or exhausted (smaller,
referred to as “old”) platelets in the population of single platelets,
as well as between single and “clumped” platelets (CD41/61-posi-
tive cells) in resting, non-stimulated blood.
The diameter of the platelets in blood samples was determined
using a standard curve prepared with FSC calibration beads
covering the following size ranges: 0.5, 1, 2–2.4, 3–3.4, 5–5.9,
7–7.9, 8–12.9, 13–17.9 µm.
It should be borne in mind that the use of artificial beads for
any size‐related calibrations is imprecise, as the beads and plate-
lets display different refractive indices. Therefore, our intention
was not to determine the exact size of platelets in blood samples,
but rather to reveal the differences in the cohorts of newly pro-
duced and exhausted platelets and in the forming of “larger”
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platelet aggregates/clumps, between diabetic and healthy mice,
that would reflect the activation state of circulating platelets in
tested groups of animals.
Concentration and functionality of vWF in plasma
Whole blood, collected as described above, was centrifuged at
800 × g for 15 minutes at 4°C. Von Willebrand factor was
assayed in plasma with the use of enzyme-linked immunosorbent
assay according to manufacturer’s instructions.
Twenty-five microliters of blood collected from a healthy
mouse was diluted 25-fold with Tyrode’s buffer, spun down
(900 × g, 5 minutes), the supernatant was discarded and the
cellular blood components were reconstituted in 25-fold times
diluted plasma from either STZ-diabetic or nondiabetic mouse.
Flow cytometry analysis of vWF binding to platelets in response
to ristocetin (at a final concentration of 12.5 mg/ml) was con-
ducted as described above.
Histochemistry and immunohistochemistry
To create histochemical images, formaldehyde-fixed (4% in PBS)
and paraffin-embedded mesenteries were cut to small sections (4
µm). The sections were mounted on superfrost slides, then
dewaxed with xylene, hydrated, and boiled in the antigen retrieval
solution buffer for 10 minutes. All sections were counterstained
with Meyer’s hematoxylin. Imaging was performed with the use
of the AxioVert inverted microscope (Carl Zeiss, Oberkochen,
Germany) with a standard color CCD camera (magnitude 400x).
To perform vWF staining, the mesenteries were cut into 5 μm-
thick cross-sections using Accu-Cut SMR 200 rotary microtome
(Sakura Finetek, Tokyo, Japan) and collected on polylysine-cov-
ered microscopic slides. The cross-sections were de-paraffinized,
using a Leica ST5020 multistaining station (Leica, Wetzlar,
Germany), and incubated in a citrate buffer (95°C/30 minutes.)
according to the standardized heat-induced epitope retrieval
(HIER) protocol. To minimize nonspecific antibody binding,
slides were pre-incubated in blocking solution containing 5%
normal goat serum, 2% dry milk, and 0.1% Triton X-100 for 45
minutes. Primary rabbit-anti-mouse von Willebrand factor anti-
body was applied for a 1-hour incubation period, followed by a
30-minute incubation with Cy3-conjugated secondary goat-anti-
rabbit antibody. Finally, the nuclei were counterstained with
Hoechst 33258 fluorescent dye. The images of mesenteric vessels
were taken using an AxioObserver D1 inverted fluorescent micro-
scope and AxioCam HRm monochromatic digital camera (Carl
Zeiss, Oberkochen, Germany). Image analysis was performed
semi-automatically using Axio Vision 4.8 software (Carl Zeiss,
Oberkochen, Germany).
Statistics
Data are expressed as mean ± SD for normally distributed vari-
ables, or as median and interquartile range (IQR: lower [25%] to
upper [75%] quartile) otherwise. The normal distributions of data
were verified with Shapiro–Wilk’s test and variance homogeneity
tested with Levene’s test. Unpaired Student’s t-test was employed
to reason on the significance of differences when comparing two
independent groups with distributions not departing from normal-
ity. In some cases, for normally distributed data when the assump-
tion of homoscedasticity was violated, we used the planned
comparisons with the Welch’s test. When normality assumption
was violated, we made an attempt to transform the raw data using
the Box-Cox transformation. If the assumptions were still not met,
the significance of differences was tested with Mann–Whitney’s
U test. When comparing multiple data sets we used one-way or
two-way block ANOVA (with relevant post-hoc multiple compar-
isons tests), and in the case when our data were not satisfying the
criterion of normality and/or variance homogeneity, the Kruskal–
Wallis’ test followed by post-hoc Dunn’s test for multiple com-
parisons was used. In addition, due to relatively small sample
sizes and the low statistical power of the estimated inferences in
some calculations, we employed the resampling bootstrap techni-
que (1000–10 000 iterations) to determine how likely it would be
to obtain the revealed differences due to a pure chance. In such
circumstances we refer to the bootstrap-boosted test statistics
(1000 iterations) instead of the classical approach. For some
variables, the overall population of data was decomposed into
two exponentially modified Gaussian partial distributions (sub-
populations) with the use of the Data Mining-assisted generalized
cluster analysis by EM (expectation–maximization) algorithm.
Statistical analysis was performed using Statistica v. 12.5 and
Resampling Stats Add-in for Excel v.4.
Results
Streptozotocin-induced diabetes
Postprandial glucose levels on the day of the experiment were
significantly higher in mice treated with STZ than those treated
with citrate: 30.6 ± 1.3 mmol/l vs 8.0 ± 4.6 mmol/l (mean ±
SD), respectively; p < 0.001 (unpaired, one-sided, Student’s
t-test), n = 11.
The numbers and sizes of platelets in control and diabetic
mice subjected to hematological analysis
The numbers of platelets were 948 ± 63 x 103 plt/µl in control
mice and 883 ± 131 x 103 plt/µl (mean ± SD) in STZ mice. The
difference was not statistically significant (Student’s t-test).
However, the mean platelet volume was significantly lower in
control mice, 4.9 (4.8; 4.9) fL, than in STZ diabetic mice, 5.1
(4.9; 5.2) fL (median [IQR]), (Pbootstrap< 0.03), as indicated by
the bootstrap-boosted Mann–Whitney’s U test (n = 9).
Interaction of blood platelets with vascular wall
Analyses of the video sequences revealed two modes of interac-
tion between the platelets and the vessel wall: some of the objects
attached to vascular wall and remained at the same place for a
period of time while others did not remain at one site for sub-
sequent frames of the video sequence. The latter group possibly
included platelets rolling or sliding on the surface of vascular wall
(Figure 1). To quantify the results, the video sequences were
analyzed frame by frame. Each fluorescent object which could
be distinguished from the background was traced with the aid of
the software. The distance covered by each object and the linear
velocity of the objects displaced in the movie sequence were
calculated. The number of platelets interacting with the vessel
wall was normalized for a duration of a movie sequence and for
an area of the vessel. Mean values for particular mouse were
calculated based on the data obtained for the video sequences
recorded in this mouse. A total number of platelets interacting
with the vessel wall were significantly higher in the STZ than in
the control mice: 20.9 (12.5; 65.4) plt/mm2/min in non-STZ-
diabetic mice vs. 59.9 (30.9; 127.1) plt/mm2/min (median
[IQR]) in the STZ-diabetic mice (one-tailed p < 0.05 as revealed
by Mann–Whitney U test; n = 11 for control and n = 12 for STZ-
diabetic mice). To honestly evaluate these outcomes, we have to
be aware however, that there is a source of inaccuracy in counting
of all of the interacting objects. The faster an object moves, the
more difficult is to identify it. The accuracy of counting of fast
moving objects is definitely a source of error, as it strongly
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depends on (i) the quality of movie sequence, which can differ
between the fields, and on (ii) the level of efficacy of platelet
staining, which can vary between mice. Thus, in our opinion a
more accurate solution is to define a clear criterion that defines
which objects are counted. Thus, to do so, we have arbitrarily
categorized of all the observed events into two groups: (a) adher-
ing platelets, which attached and did not displace for at least two
frames (400 ms) and (b) sliding platelets. In the case of the
platelets that were not immobilized for longer than 400 ms, we
decided to compare the distributions of their velocities keeping in
mind the limitations described above (Figure 3).
The number of platelets, which at least transiently adhered to
the vessel wall, was significantly higher in mice with streptozo-
tocin-induced diabetes (Figure 2). The duration of a single event
of adhesion was not significantly different between the two
groups: 14.0 (0.7; 21.7) s (median [IQR]) in non-STZ-diabetic
animals vs. 20.7 (16.0; 29.9) s in STZ-diabetic animals (n = 11
for control and n = 12 for STZ-diabetic mice). As shown on a
histogram of velocity distribution (Figure 3a), the velocities of
platelets were lower in STZ-diabetic than in nondiabetic mice,
indicating that the platelets in these animals were more likely to
interact with vascular wall.
Since the distribution of velocities in control group appeared
bimodal, we employed the Data Mining-assisted cluster analysis
to decompose the overall population of data into two exponen-
tially modified Gaussian partial distributions (Figure 3b). The
median value of the second cluster appeared to be shifted more
toward lower velocities in STZ-diabetic mice than in nondiabetic
animals, which further confirms that platelets in STZ animals are
more prone to interact with the vascular wall.
Microscopic observations also revealed in STZ mice the occa-
sional appearance of objects that could be identified as blood
platelets forming strings on vWF released by the activated
endothelium (Figure 1) as described in the literature [18, 19].
In the experiment testing the effect of blocking antibodies on
the platelet adhesion, platelets which were adherent at the begin-
ning of recording were excluded from the calculation. The ratio-
nale for this decision was that these platelets could have adhered
prior to injection of blocking antibodies, and so could have been
potential false negative observations regarding the effectiveness
of the blocking antibodies. As shown in Figure 4, the number of
platelets transiently adhering to the vascular wall was signifi-
cantly lower in mice injected with anti-GPIbα blocking antibo-
dies. In mice treated with anti-GPIIb/IIIa blocking antibodies the
number of adhering platelets was lower but did not reach statis-
tical significance. The use of blocking antibodies was found to
have no effect on the velocities of the sliding platelets.
Flow cytometry analysis of platelet activation, reactivity, and
size
Flow cytometry analysis revealed that the circulating platelets
demonstrated higher activation in STZ-diabetic mice than control
Figure 1. In vivo imaging of blood platelet adhesion to the vascular wall
in control and STZ-diabetic mice. Mice were injected with anti-GPIbβ
antibodies conjugated with DyLight488. Observations were carried out in
the mesentery vascular bed under an upright fluorescence microscope
equipped with a water immersion objective. (a) Two representative
frames are shown for control and STZ group. Adherent platelets are
seen as dots, while streaks represent those platelets, which displaced
during the exposure period. (b) Objects observed occasionally in STZ
mice which appearance was similar to the “strings” of vWF decorated
with blood platelets.
Figure 2. The number of platelets immobilized for at least 400 ms on
mesenteric vascular wall in control and STZ-diabetic mice. Results
shown as median (horizontal line) with interquartile range (box) and
raw data. Significance of differences tested with Mann–Whitney U test.
** p < 0.01; n = 11 for control and n = 12 for STZ-diabetic mice.
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mice (Figure 5), as evidenced by increased expression of CD62P,
active GPIIb/IIIa, and bound vWF. Upon the stimulation of plate-
lets with AYPGKF (PAR-4 agonist), we obtained significantly
higher platelet response in STZ-diabetic as compared to vehicle-
injected mice, for all the tested markers of platelet activation
(Figure 5). This discrimination between diabetic and nondiabetic
mice was apparent regardless of the concentration of PAR-4
activating peptide.
As described above, our microscopic observations revealed
occasional events which could be interpreted as the formation
of platelet aggregates on vWF released by activated endothe-
lium. Therefore, the next part of the study examined the dis-
tribution of smaller objects (referred to as normal (single)
blood platelets or normoplatelets) and larger objects (referred
to as platelet clumps or platelet aggregates) in blood from
control and STZ animals. It was found that the proportion of
the fraction of “platelet aggregates” to the fraction of “normo-
platelets” was significantly higher in STZ mice, clearly
indicating that “platelet aggregates” were much more abundant
in diabetic animals (Figure 5). With regard to the difference
between the fraction of vWF-positive platelets, the binding of
vWF to platelets was approximately equally distributed
between “normoplatelets” and “aggregates” in control animals,
but was significantly higher in the subpopulation of platelet
“aggregates” in STZ animals (Figure 5).
Adhesion of blood platelets to vWF in flow conditions
To evaluate whether the enhanced propensity of platelets to interact
with vWF in STZ mice was an intrinsic feature of these platelets the
next part of the study measured their ability to interact with immo-
bilized vWF under flow conditions. The number of blood platelets
which remained adhered to a surface coated with von Willebrand
factor for at least 2 seconds did not differ significantly between
control and STZ diabetic mice (Figure 6).
Figure 3. Quantification of platelet velocities. (a) Histogram showing distribution of platelet velocities in control and STZ-diabetic mice; blood
platelets, which were immobilized on mesenteric vascular wall for a period shorter than 400 ms, were considered as sliding on a vessel wall; the
median of velocities with interquartile range was equal to 62.5 (18.9; 306.1) μm/s in control group and to 11.8 (0.4; 36.3) μm/s in STZ-diabetic mice;
the analysis of differences between groups was conducted for mean velocities calculated for each mouse with a blocked ANOVA, p < 0.0001; n = 11
for control and n = 12 for STZ mice. (b) The decomposition of the exponentially modified Gaussian curves circumventing the histograms reveals two
populations of platelets in terms of their adhesive properties. Probability density function of the timespan of adhesion for both groups is given by
Poisson distribution: μ
xeμ
x! ; where μ is respective median velocity and x is a velocity for which the probability is calculated.
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Von Willebrand factor concentration and functionality assay
in plasma
The concentration of soluble vWF in plasma was 88.7 ± 28.7 ng/
ml (mean ± SD) in control mice and 106.6 ± 38.2 ng/ml (mean ±
SD) in STZ mice. The difference was not statistically significant
(p = 0.079; one-tailed Student’s t-test; n = 17 for control and n =
14 for STZ mice).
Ristocetin caused a significant increase in the binding of vWF
to platelets from plasma: 75.8 ± 9.5 % after ristocetin vs. 13.0 ±
0.9 % (mean ± SD) in the non-treated plasma. However, the
binding in the STZ and the control plasma was not significantly
different: 78.2 ± 8.1 % in the control and 72.7 ± 5.0% (mean ±
SD) in plasma of STZ diabetic mice.
Histochemistry
Fluorescent immunohistochemical staining of vWF in mesenteric
vessels demonstrated significantly higher expression of the pro-
tein in the endothelium of STZ-diabetic mice (Figure 7).
The histochemical staining of mesenteric blood vessels did
not reveal any substantial changes in endothelial morphology,
such as loss of integrity and detachment of endothelial cells
from basement membrane, in STZ-diabetic mice compared to
other animal models of dysfunctional endothelium [20, 21]
(Figure 8). A subtle edema of some of the endothelial cells
was observed in selected specimens of STZ-diabetic mice; this
was not observed in the control mice and could be possibly
interpreted as a sign of dysfunction (see Additional file 1).
Discussion
The paper is the first to show that blood platelets in a mouse
model of diabetes are more likely to interact with an intact
vascular wall than those in nondiabetic animals. The interaction
of platelets with the endothelium in vivo in diabetic animals has
not been previously examined but it has been shown that chronic
hyperglycemia leads to endothelial activation and renders it more
adhesive for leukocytes. Increased rolling of leukocytes was
observed in vivo in the mesentery in rats with 2-week STZ
diabetes [22].
Our recorded interactions were generally short-lasting, the
platelets were transiently adhering or sliding on the vessel
wall. Although a higher frequency of platelet interactions
with the endothelium was observed in diabetic than nondia-
betic mice, the difference between the median durations of a
single interaction in these two groups was of marginal sig-
nificance. These findings show that 1-month STZ-induced
diabetes results in moderate alteration of adhesive properties
of the vascular wall in the mesentery. When compared to
another mouse model of metabolic disorder associated with
endothelium dysfunction, the effects observed in our experi-
ment were relatively mild. In ApoE–/– mice, which sponta-
neously develop atherosclerosis, Massberg et al. report much
more numerous events of firmly adhering platelets [6] in sites
which are more susceptible to the development of athero-
sclerotic lesions, i.e., the bifurcation of the common carotid
artery. The increased binding of platelets in this model was
observed before any histological evidence of atherosclerotic
lesions could be found. Similarly, in our model, histological
examination of the mesenteric vascular bed did not reveal any
apparent deterioration of the endothelial layer or any forma-
tion of atherosclerotic plaque.
The increased frequency of interactions assessed in our
studies could be explained by enhanced basal activation and
reactivity of blood platelets, as revealed by flow cytometry. It
is accepted that one of the main proteins involved in the
interaction of a platelet with the activated endothelium is
fibrinogen, which is bound to VCAM and ICAM on endothe-
lial cells [23]. The platelets of the STZ-diabetic mice in the
present study demonstrated increased expression of the active
form of GPIIb/IIIa which binds fibrinogen. This is in agree-
ment with studies published previously [11, 24]. Another pair
of proteins thought to contribute to the interaction between
platelets and the inflamed endothelium is the binding of GPIb
to vWF or P-selectin present on the endothelium.
To verify which of the two platelet receptors contributed to
the greatest extent in our model, the effect of respective
blocking antibodies on platelet adhesion was examined. To
avoid thrombocytopenia, known to be caused by the injection
of entire IgG [25], Fab fragments were used. While the
enhanced propensity of interactions was decreased by GPIb
receptor blocking, GPIIb/IIIa blocking effect was not signifi-
cant. The lack of significance might be an effect of a low
sample size, thus we do not exclude the contribution of
GPIIb/IIIa in these enhanced interactions. In a study of
ApoE–/– mice, Massberg et al. noted that inhibition of
GPIIb/IIIa reduced the firm adhesion of platelets, defined as
lasting more than 20 seconds, but had no effect on transient
interactions. In turn, GPIb inhibition significantly decreased
both firm and transient interactions [6]. Hence, the contribu-
tion of GPIIb/IIIa to the interactions seems to be more pro-
minent in the carotid artery of ApoE–/– mice than these
observed in our model. It could be suggested that in our
model of endothelial dysfunction is not severe enough to
Figure 4. The effect of blocking antibodies on the number of platelets
immobilized for at least 400 ms on the mesenteric vascular wall in
streptozotocin-injected (STZ) mice. Results shown as median (horizontal
line) with interquartile range (box) and raw data; n = 7 for isotype
antibodies injected mice, n = 6 for anti-GPIIb/IIIa and n = 6 for anti-
GPIbα. Significance of differences tested as planned comparisons with
one-tailed Welch’s test, followed by the bootstrap-boosted one-tailed
Student’s t-test with the Bonferroni’s correction for multiple comparisons
(in parentheses); *pWelch< 0.02 (pbootstrap = 0.0086),
#pWelch= 0.0614
(pbootstrap = 0.0718).
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support firm interaction of platelet GPIIb/IIIa with its ligand
on the vascular wall. It is thus obvious that the pattern of
interaction of platelets with the endothelium in pathological
conditions is associated with the type of metabolic disorder,
the type of vascular bed and possibly with the severity of the
endothelial dysfunction.
This hypothesis can be supported by the similar findings
derived from a model of acute activation of intact endothelium
in the mesentery vasculature in mice. In mouse mesenteric
venules stimulated with calcium ionophore A23187, platelet
adhesion was found not to be dependent on GPIIb/IIIa, as the
wt platelets and the platelets lacking β3 integrin were found to
adhere equally efficiently [26]. Interestingly, A23187-stimu-
lated adhesion was absent in vWF–/– mice, which clearly
indicated that the degree of GPIb binding to vWF fully
accounted for the interaction with vascular wall. In addition,
topical application of the ionophore resulted in a rapid accu-
mulation of adhering platelets, and these platelets detached
shortly after the cessation of stimulation. The authors deduced
that the adhesion events were not sufficient to develop firm
adhesion of platelets stabilized by GPIIb/IIIa. Their immuno-
histochemistry analysis found the endothelium of venules
remained intact after treatment with the ionophore. Similarly,
our findings did not reveal the presence of any significant
deterioration of the endothelial layer. Thus, the endothelium
of the mesentery in mice with 1-month diabetes resembles the
platelet adhesion conditions generated by transient activation,
resulting in the mobilization of endothelial vWF pool.
In line with these expectations, we have detected higher
expression of vWF in the endothelium of mesenteric vessels
of STZ mice. Interestingly, this was not associated with
increased levels of circulating vWF in the plasma of STZ
mice. These apparently contradictory results can be explained
by another finding: flow cytometry analysis revealed a signifi-
cantly higher pool of vWF positive platelets in STZ mice, most
of which were in the aggregates fraction. This, along with the
microscopic observations of the events resembling blood plate-
lets forming strings on vWF in STZ mice, could suggest that
platelets could rapidly bind to vWF secreted by and immobi-
lized on the endothelium. Further, once vWF undergoes the
Figure 5. Flow cytometry analysis of changes of selected markers of platelet activation in response to protease-activated receptor-4 (PAR-4) activating
peptide (AYPGKF). (a) Concentration “0” represents the basal activation of platelets. Results are shown as median (horizontal line) with interquartile
range (box). The significance of differences between the control (light grey) and STZ-diabetic (dark grey) groups was tested with the bootstrap-boosted
Mann–Whitney U test for resting platelets and for each concentration of PAR-4 activating peptide, **pbootstrap< 0.02 or lower; n = 6. (b) The sizes of
CD61/CD41-positive objects in the subpopulations of normoplatelets (cluster 1) and aggregates (cluster 2) in whole blood samples from nondiabetic
and streptozotocin-diabetic mice. The objects were discriminated based on flow cytometry forward scatter data, with the use of the Data Mining-
assisted generalized cluster analysis by EM (expectation–maximization) algorithm, which decomposes the overall population into two exponentially
modified Gaussian partial distributions relevant to platelet subpopulations representing small objects (normoplatelets, predominantly single blood
platelets) and larger objects (platelet aggregates with other blood cells) in nondiabetic (light grey) and STZ-induced diabetic (dark grey) mice. Object
sizes were estimated from the standard curve assigned with FSC calibration beads (size range of 1 µm to 15 µm). The contributions of normoplatelets
and aggregates were 77.6% vs. 22.4% in nondiabetic and 50.6% vs. 49.4% in STZ-diabetic animals (p < 0.0001 for aggregates: 22.4 ± 3.1% in control
vs. 49.3 ± 9.1% in diabetic mice, bootstrap estimate of an unpaired Student’s t-test, 1000 iterations). (c) The relative fraction of vWF-positive platelets
in pools of “normoplatelets” and “aggregates” in nondiabetic (left) and STZ-diabetic mice (right). Results shown as median (horizontal line) with
interquartile range (box) and raw data, ***p < 0.001, n = 9.
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fragmentation mediated by the action of ADAMTS-13, the
aggregates of platelets rich in vWF may have become released,
as it has been described previously in other models of the
endothelial activation [18, 19, 27]. Due to this phenomenon,
an excessive amount of vWF released by the activated endothe-
lium in STZ mice circulates as being bound to platelets rather
than as a free soluble form and its increased levels in plasma
are not detected. At the same time, it has to be kept in mind
that some fraction of platelet-bound vWF could also be a
portion of the protein secreted from platelets that had under-
gone activation in a circulation. In our experiments, the stimu-
lation of platelets with PAR-4 activating peptide in plasma-
depleted blood, where presumably only traces of vWF were
present, resulted in a significant increase in platelet-bound
vWF, which suggests that platelets activated in a circulation
could release vWF and could be detected as vWF-positive.
Until now, however, there is no way to discriminate between
the two pools of vWF with the use of flow cytometry.
Apparently, increased vWF expression on the platelet surface
in diabetic animals is a marker of platelet activation or
endothelial dysfunction. Further investigation of the source of
vWF on platelets in diabetes and other pathologies could be an
interesting step toward improving our knowledge in the field of
markers of vascular dysfunction. This would, however, demand
novel tools such as antibodies specific against platelet-
derived vWF.
It has been shown that vWF in the patients with diabetes
underwent carbonylation, which was associated with thrombo-
tic complications, and that the level of high molecular weight
multimers of this protein was also increased [28]. Thus, it can
be taken into consideration that not only the increased
deposition of vWF on endothelium in diabetic mice, but also
an altered structure of the protein contributed to the enhanced
interaction of platelets with vascular wall. We could not per-
form the analysis of a structure of vWF bound to the endothe-
lium in the STZ mice. In turn, we made an attempt to evaluate
the ability of the binding of plasma soluble pool of vWF to
normal platelets in a ristocetin assay. This experiment did not
reveal any significant difference in a functionality of a soluble
vWF between STZ-diabetic and nondiabetic animals. However,
as it has been stated above, we hypothesize that the plasma
soluble fraction of vWF may not be representative for the vWF
pool secreted by the activated endothelium.
Finally, we also evaluated whether platelets from the STZ-
diabetic animals were more prone to interact in flow conditions
with the immobilized vWF. This functional assay did not reveal
such a tendency. Taking into account the fact that platelets in
STZ mice presented higher levels of the activated GPIIb/IIIa
receptor and were more reactive, the lack of their enhanced
interactions with the immobilized vWF suggests that alterations
in platelet function do not explain their enhanced interactions
with vessel wall observed in vivo. This once again points at an
important role of vWF present on the activated endothelium of
the STZ mice.
There is yet another factor, which can also explain an
increased affinity of blood platelets to the endothelium in dia-
betes. Recent studies revealed that streptozotocin-induced dia-
betes in rats increased blood viscosity already 3 days after an
onset of diabetes [29]. It is of special interest in terms of the
interaction between GPIb receptor with vWF. It has been shown
that rolling velocity of blood platelets on vWF decreases with
the increase of wall shear stress within its physiological range
[30]. Since shear stress increases with an increase of fluid
viscosity, the rheological changes in blood in the STZ animals
may also contribute to an enhanced interaction of platelets with
vWF deposited on the endothelium. Whether an altered blood
viscosity really contributed to the rheological changes in blood
in the STZ animals in this particular case remains obscure, as far
as the putative contributions of various factors influencing such
a viscosity (glucose, fibrinogen), although supported by a litera-
ture, were not examined in this study and hence, their roles
remain rather elusive.
Lowered concentration of insulin in STZ model of diabetes
add some complexity to the understanding of the mechanisms
of the observed phenomena, as insulin acts in an opposite way
on the main components described in the paper. It has been
shown that insulin increased platelet activation [31] and that
lack of insulin signaling decreased the activation of platelets
[32, 33]. On the other hand, insulin stimulates expression of
endothelial nitric oxide in endothelial cells [34] and maintains
endothelial function [35, 36]. Interestingly, concentrations of
IGF-1, another protein from insulin family, which also has a
receptor on platelets, were increased in 4-week STZ-diabetes
mice and signaling through this receptor enhanced platelet
hyperreactivity in these mice [37]. The phenotype which we
observed in our model could be a direct effect of an altered
insulin signaling or it can be a consequence of hyperglycemia.
We do not have a firm evidence at present which particulate
factor exhibited the largest contribution in our model: whether
it was hyperglycemia or other concurrent factors encountered
in diabetic state. The elucidation of the mechanisms leading to
the occurrence of this particular phenotype was beyond the
scope of the presented study, but remains a subject of our
currently performed research.
To summarize, we conclude that platelets interact more fre-
quently with the mesenteric vascular bed in mice with 1-month
Figure 6. Number of blood platelets of control and STZ mice adhered to
von Willebrand factor under flow conditions. Results shown as median
(horizontal line) with interquartile range (box) and raw data. Significance
of differences tested with Mann–Whitney test, n = 8 for control mice and
n = 10 for STZ mice.
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STZ-induced diabetes than in healthy mice. These interactions are
mediated via platelet GPIb-IX-V and are driven by increased
expression of vWF in endothelial cells.
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